A systematic review and meta-analysis of 16 studies involving nearly 2 million participants found that higher red meat intake ...
A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay disease progression in men with specific DNA repair gene mutations. In the ...
A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results